BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 16765116)

  • 1. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
    van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
    Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
    Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty.
    de Winter RJ; Heyde GS; Koch KT; Fischer J; van Straalen JP; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; Piek JJ; Tijssen JG
    Eur Heart J; 2002 Jun; 23(12):960-6. PubMed ID: 12069451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative high sensitive C-reactive protein predicts cardiovascular events after coronary artery bypass grafting surgery: a prospective observational study.
    Balciunas M; Bagdonaite L; Samalavicius R; Griskevicius L; Vuylsteke A
    Ann Card Anaesth; 2009; 12(2):127-32. PubMed ID: 19602737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative C-reactive protein levels to predict early and late mortalities after coronary artery bypass surgery: eight years of follow-up.
    van Straten AH; Soliman Hamad MA; van Zundert AJ; Martens EJ; Schönberger JP; de Wolf AM
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):954-8. PubMed ID: 19660390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.
    O'Malley T; Ludlam CA; Riemermsa RA; Fox KA
    Eur Heart J; 2001 Jul; 22(14):1226-34. PubMed ID: 11440495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events?
    Hedman A; Larsson PT; Alam M; Wallen NH; Nordlander R; Samad BA
    Int J Cardiol; 2007 Aug; 120(1):108-14. PubMed ID: 17141340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis.
    Palmerini T; Marzocchi A; Marrozzini C; Reggiani LB; Savini C; Marinelli G; Di Bartolomeo R; Branzi A
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):685-90. PubMed ID: 17236785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
    Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
    Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study.
    Walter MF; Jacob RF; Jeffers B; Ghadanfar MM; Preston GM; Buch J; Mason RP;
    J Am Coll Cardiol; 2004 Nov; 44(10):1996-2002. PubMed ID: 15542282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery.
    van de Wal RM; van Brussel BL; Voors AA; Smilde TD; Kelder JC; van Swieten HA; van Gilst WH; van Veldhuisen DJ; Plokker HW
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):330-5. PubMed ID: 15678043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
    Blankenberg S; McQueen MJ; Smieja M; Pogue J; Balion C; Lonn E; Rupprecht HJ; Bickel C; Tiret L; Cambien F; Gerstein H; Münzel T; Yusuf S;
    Circulation; 2006 Jul; 114(3):201-8. PubMed ID: 16831981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.
    Kofidis T; Gerd Paeschke H; Lichtenberg A; Emmert M; Woitek F; Didilis V; Haverich A; Klima U
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):49-53. PubMed ID: 18786942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
    Ridker PM; Hennekens CH; Buring JE; Rifai N
    N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
    Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
    Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.